Announcements Trials
Browse Landscape

Phase

Phase 2 7

Status

Recruiting 26Completed 13Active not recruiting 13Not yet recruiting 7Terminated 4Withdrawn 3Unknown 3

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Lymphoid 7Sarcoma 2

Conditions

Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Mantle-Cell 1Lymphoma, B-Cell 1Lymphoma 1

Interventions

Cyclophosphamide 31Rituximab 23zanubrutinib 18Vincristine 15fludarabine 14Prednisone 14venetoclax 13blinatumomab 12Specimen Handling 12Magnetic Resonance Spectroscopy 12Doxorubicin 12obinutuzumab 10Bendamustine Hydrochloride 10Lenalidomide 9Dexamethasone 8polatuzumab vedotin 7glofitamab 7Methotrexate 7Biopsy 7Radiotherapy 6Prednisolone 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Cytarabine 6pirtobrutinib 5pegaspargase 5Immunotherapy, Adoptive 5tislelizumab 4tafasitamab 4selinexor 4orelabrutinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Not yet recruiting × polatuzumab vedotin × Lymphoid × Clear all
NCT06594939 2026-05-01

Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma

Medical College of Wisconsin

Phase 2 Not yet recruiting
31 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT07502872 2026-03-31

TPG

Brown University

Phase 2 Not yet recruiting
30 enrolled
Lymphoid

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT06665217 2025-08-14

G-Pola-ZLP in Diffuse Large B-Cell Lymphoma

Navy General Hospital, Beijing

Phase 2 Not yet recruiting
80 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT07012980 2025-06-10

Glofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCL

Shanghai Zhongshan Hospital

Phase 2 Not yet recruiting
38 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT06516978 2024-07-24

A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Not yet recruiting
528 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT06441097 2024-06-04

Efficacy of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL

Ruijin Hospital

Phase 2 Not yet recruiting
152 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04913103 2021-06-04

CLSGMCLPOLA

Czech Lymphoma Study Group

Phase 2 Not yet recruiting
21 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡